Blood thinners and psilocybin.
6 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as blood thinner · anticoagulant · antiplatelet
01 What the evidence covers
Best evidence available per medication| 6 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZStroke prevention in atrial fibrillation (not caused by a heart valve problem); Blood clot prevention after hip or knee replacement
Not studied with psilocybin. Also, it raises bleeding risk if a fall or injury occurs, and stopping it early raises stroke and clot risk.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Minor aches and pains (headache, muscle pain, toothache, menstrual pain, arthritis); Fever
Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, more so with blood thinners or steroids.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute coronary syndrome (unstable angina and heart attack), to reduce heart attack and stroke; Recent heart attack, recent stroke or peripheral artery disease, to reduce heart attack and stroke
Not studied with psilocybin; no linking mechanism is described. It raises bleeding risk, so a fall while coordination is impaired may cause more injury.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Stroke prevention in atrial fibrillation (not caused by valve disease); Deep vein thrombosis and pulmonary embolism, treatment and recurrence prevention
Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, and stopping it early raises the risk of blood clots.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Lowering risk of heart attack, stroke and cardiovascular death after acute coronary syndrome or a prior heart attack; Lowering risk of a first heart attack or stroke in high-risk coronary artery disease
Not studied with psilocybin; it raises bleeding risk from falls or injuries. Also, stopping it raises the risk of heart and blood-vessel events.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Blood clots in veins (venous thrombosis) and pulmonary embolism (prevention and treatment); Clot complications from atrial fibrillation or heart valve replacement
Not studied with psilocybin; no linking mechanism is described; it raises bleeding risk, so a fall during a session can cause serious bleeding.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 3 | Withdrawal or rebound if stopped abruptly |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRecords reviewed 2026-10-03. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z